Correlation Between Liaoning Chengda and Ningbo MedicalSystem

Can any of the company-specific risk be diversified away by investing in both Liaoning Chengda and Ningbo MedicalSystem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Liaoning Chengda and Ningbo MedicalSystem into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Liaoning Chengda Biotechnology and Ningbo MedicalSystem Biotechnology, you can compare the effects of market volatilities on Liaoning Chengda and Ningbo MedicalSystem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Liaoning Chengda with a short position of Ningbo MedicalSystem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Liaoning Chengda and Ningbo MedicalSystem.

Diversification Opportunities for Liaoning Chengda and Ningbo MedicalSystem

0.97

Correlation Coefficient

Liaoning Chengda  Ningbo MedicalSystem

Almost no diversification

The 3 months correlation between Liaoning and Ningbo is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding Liaoning Chengda Biotechnology and Ningbo MedicalSystem Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ningbo MedicalSystem and Liaoning Chengda is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Liaoning Chengda Biotechnology are associated (or correlated) with Ningbo MedicalSystem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ningbo MedicalSystem has no effect on the direction of Liaoning Chengda i.e., Liaoning Chengda and Ningbo MedicalSystem go up and down completely randomly.

Pair Corralation between Liaoning Chengda and Ningbo MedicalSystem

Assuming the 90 days trading horizon Liaoning Chengda Biotechnology is expected to under-perform the Ningbo MedicalSystem. But the stock apears to be less risky and, when comparing its historical volatility, Liaoning Chengda Biotechnology is 1.4 times less risky than Ningbo MedicalSystem. The stock trades about -0.01 of its potential returns per unit of risk. The Ningbo MedicalSystem Biotechnology is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  1,334  in Ningbo MedicalSystem Biotechnology on September 3, 2024 and sell it today you would lose (173.00) from holding Ningbo MedicalSystem Biotechnology or give up 12.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Liaoning Chengda Biotechnology  vs.  Ningbo MedicalSystem Biotechno

Liaoning Chengda Bio

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Liaoning Chengda Biotechnology are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Liaoning Chengda sustained solid returns over the last few months and may actually be approaching a breakup point.

Ningbo MedicalSystem

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Liaoning Chengda and Ningbo MedicalSystem

The main advantage of trading using opposite Liaoning Chengda and Ningbo MedicalSystem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Liaoning Chengda position performs unexpectedly, Ningbo MedicalSystem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ningbo MedicalSystem will offset losses from the drop in Ningbo MedicalSystem's long position.

The idea behind Liaoning Chengda Biotechnology and Ningbo MedicalSystem Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.